Alirocumab
Top SEO sites provided "Alirocumab" keyword
high ldl-c injection treatment | repatha® (evolocumab)
#alirocumab
#praluent pen
#list reports
#my praluent
#repatha injection
#repatha side effects
#ldl cholesterol
Site reached rank 8.36M. Site running on ip address 35.197.253.61
#affirmant health partners
#jackson health network
#community resource
#arch collaborative
#cmio salary
#pcc mychart
#classen symposium 2019
#jackson transit authority phone number
#jta bus schedule
#jackson transit authority bus routes
#jackson transit authority
#praluent
#alirocumab
#praluent pen
#list reports
#my praluent
#united way of jackson county
#meet alice
#consumers energy care program
#united way cardboard boat race
#care program
Keyword Suggestion
Related websites
Alirocumab Injection: Uses, Dosage, Warnings, & Side Effects - Drugs.com
WEBMar 13, 2024 · alirocumab is an injectable medicine that is given under your skin and may be used in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of chest pain conditions (unstable angina); or to treat high blood chole
Drugs.comAlirocumab - Wikipedia
WEBalirocumab, sold under the brand name Praluent, is a medication used as a second-line treatment for high cholesterol for adults whose cholesterol is not controlled by diet and statin treatment. It is a human monoclonal antibody that belongs to a novel class of anti-cholesterol drugs, known as PCSK9 inhibitors , and it was the first such agent
En.wikipedia.orgAbout PRALUENT | PRALUENT® (alirocumab) Injection
WEBWhat is PRALUENT ® (alirocumab)? PRALUENT is an injectable prescription medicine used: in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of chest pain conditions (unstable angina) requiring hospitalization.
Praluent.comAlirocumab (Subcutaneous Route) Description and Brand Names - Mayo Clinic
WEBDescriptions. alirocumab injection is used together with a proper diet and other medicines (eg, ezetimibe, statin medicine) to treat patients with primary hyperlipidemia (including heterozygous familial hypercholesterolemia) or with homozygous familial hypercholesterolemia (HoFH), who need additional lowering of their bad cholesterol (LDL).
Mayoclinic.orgEfficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular
WEBApr 16, 2015 · alirocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9), has been shown to reduce low-density lipoprotein (LDL) cholesterol levels in patients who
Nejm.orgAlirocumab and Cardiovascular Outcomes after Acute Coronary …
WEBNov 7, 2018 · Patients who have had an acute coronary syndrome are at high risk for recurrent ischemic cardiovascular events. We sought to determine whether alirocumab, a human monoclonal antibody to
Nejm.orgAlirocumab: Uses, Interactions, Mechanism of Action - DrugBank …
WEBNov 11, 2015 · alirocumab is a PCSK9 inhibitor used as an adjunct to manage heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in patients who require additional lowering of LDL-cholesterol (LDL-C).
Go.drugbank.comPraluent (alirocumab) dosing, indications, interactions, adverse
WEBMedscape - Hypercholesterolemia dosing for Praluent (alirocumab), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost
Reference.medscape.comAlirocumab (Praluent) for the Treatment of Hyperlipidemia - AAFP
WEBAug 15, 2016 · alirocumab is a novel lipid-lowering therapy that is highly effective at lowering LDL cholesterol when used in addition to statin therapy and diet.
Aafp.orgReduce the Risk of Future CV Events | PRALUENT® (alirocumab…
WEBWhat is PRALUENT ® (alirocumab)? PRALUENT is an injectable prescription medicine used: in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of chest pain conditions (unstable angina) requiring hospitalization.
Praluent.com